vs
Mirion Technologies, Inc.（MIR）与Owlet, Inc.（OWLT）财务数据对比。点击上方公司名可切换其他公司
Mirion Technologies, Inc.的季度营收约是Owlet, Inc.的10.4倍（$277.4M vs $26.6M）。Mirion Technologies, Inc.净利率更高（6.2% vs -34.6%，领先40.8%）。Owlet, Inc.同比增速更快（29.6% vs 9.1%）。Mirion Technologies, Inc.自由现金流更多（$63.2M vs $-651.0K）。过去两年Owlet, Inc.的营收复合增速更高（34.2% vs 20.0%）
Mirion Technologies是全球领先的辐射检测、监测与安全解决方案提供商，核心产品涵盖个人剂量测量系统、辐射成像设备及辐射风险管理软件，服务核电、医疗、国防、工业等多个核心领域，客户遍布北美、欧洲及亚太地区。
Owlet, Inc.是一家专注于儿科健康科技的企业，核心产品为可穿戴婴儿智能监测袜，可实时追踪婴幼儿心率、血氧水平及睡眠数据，产品通过自营电商和零售合作伙伴销往全球多个市场，为新手父母提供育儿健康支持。
MIR vs OWLT — 直观对比
营收规模更大
MIR
是对方的10.4倍
$26.6M
营收增速更快
OWLT
高出20.5%
9.1%
净利率更高
MIR
高出40.8%
-34.6%
自由现金流更多
MIR
多$63.9M
$-651.0K
两年增速更快
OWLT
近两年复合增速
20.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $277.4M | $26.6M |
| 净利润 | $17.3M | $-9.2M |
| 毛利率 | 48.8% | 47.6% |
| 营业利润率 | 9.2% | -18.4% |
| 净利率 | 6.2% | -34.6% |
| 营收同比 | 9.1% | 29.6% |
| 净利润同比 | 15.3% | -1.5% |
| 每股收益（稀释后） | $0.07 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MIROWLT
| Q4 25 | $277.4M | $26.6M | ||
| Q3 25 | $223.1M | $32.0M | ||
| Q2 25 | $222.9M | $26.1M | ||
| Q1 25 | $202.0M | $21.1M | ||
| Q4 24 | $254.3M | $20.5M | ||
| Q3 24 | $206.8M | $22.1M | ||
| Q2 24 | $207.1M | $20.7M | ||
| Q1 24 | $192.6M | $14.8M |
净利润MIROWLT
| Q4 25 | $17.3M | $-9.2M | ||
| Q3 25 | $2.9M | $4.1M | ||
| Q2 25 | $8.3M | $-37.6M | ||
| Q1 25 | $300.0K | $3.0M | ||
| Q4 24 | $15.0M | $-9.1M | ||
| Q3 24 | $-13.6M | $-5.6M | ||
| Q2 24 | $-11.7M | $-1.1M | ||
| Q1 24 | $-25.8M | $3.3M |
毛利率MIROWLT
| Q4 25 | 48.8% | 47.6% | ||
| Q3 25 | 46.8% | 50.6% | ||
| Q2 25 | 46.0% | 51.3% | ||
| Q1 25 | 47.6% | 53.7% | ||
| Q4 24 | 48.1% | 53.5% | ||
| Q3 24 | 44.9% | 52.2% | ||
| Q2 24 | 47.0% | 49.5% | ||
| Q1 24 | 45.2% | 44.4% |
营业利润率MIROWLT
| Q4 25 | 9.2% | -18.4% | ||
| Q3 25 | 3.3% | 3.8% | ||
| Q2 25 | 4.4% | -7.4% | ||
| Q1 25 | 4.3% | -12.7% | ||
| Q4 24 | 11.4% | -36.2% | ||
| Q3 24 | -0.8% | -21.8% | ||
| Q2 24 | 1.1% | -10.8% | ||
| Q1 24 | -2.5% | -39.0% |
净利率MIROWLT
| Q4 25 | 6.2% | -34.6% | ||
| Q3 25 | 1.3% | 12.9% | ||
| Q2 25 | 3.7% | -144.4% | ||
| Q1 25 | 0.1% | 14.3% | ||
| Q4 24 | 5.9% | -44.2% | ||
| Q3 24 | -6.6% | -25.4% | ||
| Q2 24 | -5.6% | -5.5% | ||
| Q1 24 | -13.4% | 22.2% |
每股收益（稀释后）MIROWLT
| Q4 25 | $0.07 | — | ||
| Q3 25 | $0.01 | $-0.06 | ||
| Q2 25 | $0.03 | $-2.37 | ||
| Q1 25 | $0.00 | $0.11 | ||
| Q4 24 | $0.08 | $-0.15 | ||
| Q3 24 | $-0.07 | $-0.61 | ||
| Q2 24 | $-0.06 | $-0.30 | ||
| Q1 24 | $-0.13 | $-0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $412.3M | $35.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $19.0M |
| 总资产 | $3.6B | $85.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MIROWLT
| Q4 25 | $412.3M | $35.5M | ||
| Q3 25 | $933.2M | $23.8M | ||
| Q2 25 | $262.6M | $21.8M | ||
| Q1 25 | $185.8M | $16.3M | ||
| Q4 24 | $175.2M | $20.2M | ||
| Q3 24 | $133.3M | $21.6M | ||
| Q2 24 | $122.2M | $15.4M | ||
| Q1 24 | $120.2M | $18.4M |
总债务MIROWLT
| Q4 25 | — | — | ||
| Q3 25 | $444.8M | — | ||
| Q2 25 | $444.9M | — | ||
| Q1 25 | $686.6M | — | ||
| Q4 24 | $686.4M | — | ||
| Q3 24 | $685.1M | — | ||
| Q2 24 | $684.1M | $2.1M | ||
| Q1 24 | $685.5M | $4.0M |
股东权益MIROWLT
| Q4 25 | $1.9B | $19.0M | ||
| Q3 25 | $1.8B | $-54.1M | ||
| Q2 25 | $1.5B | $-59.2M | ||
| Q1 25 | $1.5B | $-25.8M | ||
| Q4 24 | $1.5B | $-29.8M | ||
| Q3 24 | $1.5B | $-21.5M | ||
| Q2 24 | $1.5B | $-33.4M | ||
| Q1 24 | $1.5B | $-32.9M |
总资产MIROWLT
| Q4 25 | $3.6B | $85.6M | ||
| Q3 25 | $3.5B | $74.9M | ||
| Q2 25 | $2.7B | $63.5M | ||
| Q1 25 | $2.6B | $51.4M | ||
| Q4 24 | $2.6B | $49.5M | ||
| Q3 24 | $2.7B | $56.1M | ||
| Q2 24 | $2.6B | $45.9M | ||
| Q1 24 | $2.6B | $43.8M |
负债/权益比MIROWLT
| Q4 25 | — | — | ||
| Q3 25 | 0.24× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.47× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.0M | $-452.0K |
| 自由现金流经营现金流 - 资本支出 | $63.2M | $-651.0K |
| 自由现金流率自由现金流/营收 | 22.8% | -2.5% |
| 资本支出强度资本支出/营收 | 3.5% | 0.7% |
| 现金转化率经营现金流/净利润 | 4.22× | — |
| 过去12个月自由现金流最近4个季度 | $106.9M | $-11.1M |
8季度趋势，按日历期对齐
经营现金流MIROWLT
| Q4 25 | $73.0M | $-452.0K | ||
| Q3 25 | $22.3M | $-2.2M | ||
| Q2 25 | $12.4M | $-2.2M | ||
| Q1 25 | $35.6M | $-5.9M | ||
| Q4 24 | $60.8M | $3.0M | ||
| Q3 24 | $17.1M | $-7.5M | ||
| Q2 24 | $15.2M | $-3.4M | ||
| Q1 24 | $6.0M | $-3.4M |
自由现金流MIROWLT
| Q4 25 | $63.2M | $-651.0K | ||
| Q3 25 | $13.0M | $-2.2M | ||
| Q2 25 | $3.6M | $-2.3M | ||
| Q1 25 | $27.1M | $-5.9M | ||
| Q4 24 | $49.1M | $3.0M | ||
| Q3 24 | $3.9M | $-7.5M | ||
| Q2 24 | $4.1M | $-3.4M | ||
| Q1 24 | $-6.8M | — |
自由现金流率MIROWLT
| Q4 25 | 22.8% | -2.5% | ||
| Q3 25 | 5.8% | -6.8% | ||
| Q2 25 | 1.6% | -8.8% | ||
| Q1 25 | 13.4% | -28.1% | ||
| Q4 24 | 19.3% | 14.5% | ||
| Q3 24 | 1.9% | -33.9% | ||
| Q2 24 | 2.0% | -16.3% | ||
| Q1 24 | -3.5% | — |
资本支出强度MIROWLT
| Q4 25 | 3.5% | 0.7% | ||
| Q3 25 | 4.2% | 0.0% | ||
| Q2 25 | 3.9% | 0.2% | ||
| Q1 25 | 4.2% | 0.0% | ||
| Q4 24 | 4.6% | 0.2% | ||
| Q3 24 | 6.4% | 0.0% | ||
| Q2 24 | 5.4% | 0.0% | ||
| Q1 24 | 6.6% | 0.0% |
现金转化率MIROWLT
| Q4 25 | 4.22× | — | ||
| Q3 25 | 7.69× | -0.52× | ||
| Q2 25 | 1.49× | — | ||
| Q1 25 | 118.67× | -1.96× | ||
| Q4 24 | 4.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIR
| Transferred Over Time | $96.6M | 35% |
| Services | $65.0M | 23% |
| Cancer Care | $61.8M | 22% |
| Labs And Research | $34.0M | 12% |
| Other Care | $20.7M | 7% |
OWLT
| US | $22.7M | 85% |
| Non Us | $3.2M | 12% |
| Other | $651.0K | 2% |
